LeonaBio (LONA) Treasury Shares (2019 - 2025)
LeonaBio (LONA) reported Treasury Shares of $57601.0 for Q4 2025, down 7.48% year-over-year from $62259.0 in Q4 2024, and down 33.75% on a QoQ basis from $86949.0 in Q3 2025.
LeonaBio (LONA) has 7 years of Treasury Shares data on file, last reported at $57601.0 in Q4 2025.
- Quarterly Treasury Shares fell 7.48% year-over-year to $57601.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $57601.0 (down 7.48% YoY) and the FY2025 annual result came in at $57601.0, down 7.48% from the prior year.
- Treasury Shares slipped to $57601.0 in Q4 2025 per LONA's latest filing, from $86949.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q1 2025 and bottomed at $1576.0 in Q1 2021.
- The 5-year median for Treasury Shares is $237506.0 (2022), against an average of $282626.5.
- The widest annual swing landed in 2022, when Treasury Shares jumped 22726.78%; it then plunged 99.36% in 2024.
- Tracing LONA's Treasury Shares over 5 years: stood at $361500.0 in 2021, then plunged by 34.62% to $236339.0 in 2022, then soared by 31.2% to $310087.0 in 2023, then slumped by 79.92% to $62259.0 in 2024, then retreated by 7.48% to $57601.0 in 2025.
- Per Business Quant, the three latest LONA Treasury Shares figures stand at $57601.0 (Q4 2025), $86949.0 (Q3 2025), and $891850.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,601.00 |
| Dec 31, 2025 | 57,601.00 |
| Sep 30, 2025 | 86,949.00 |
| Sep 30, 2025 | 86,949.00 |
| Jun 30, 2025 | 891,850.00 |
| Jun 30, 2025 | 891,850.00 |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 62,259.00 |
| Dec 31, 2024 | 62,259.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 154,038.00 |
| Jun 30, 2024 | 154,038.00 |
| Mar 31, 2024 | 156,038.00 |
| Mar 31, 2024 | 156,038.00 |
| Dec 31, 2023 | 310,087.00 |
| Dec 31, 2023 | 310,087.00 |
| Sep 30, 2023 | 313,337.00 |
| Sep 30, 2023 | 313,337.00 |
| Jun 30, 2023 | 350,172.00 |
| Jun 30, 2023 | 350,172.00 |
| Mar 31, 2023 | 346,006.00 |
| Mar 31, 2023 | 346,006.00 |
| Dec 31, 2022 | 236,339.00 |
| Dec 31, 2022 | 236,339.00 |
| Sep 30, 2022 | 237,506.00 |
| Sep 30, 2022 | 237,506.00 |
| Jun 30, 2022 | 239,839.00 |
| Jun 30, 2022 | 239,839.00 |
| Mar 31, 2022 | 359,750.00 |
| Mar 31, 2022 | 359,750.00 |
| Dec 31, 2021 | 361,500.00 |
| Dec 31, 2021 | 361,500.00 |
| Jun 30, 2021 | 1,576.00 |
| Jun 30, 2021 | 1,576.00 |
| Mar 31, 2021 | 1,576.00 |
| Mar 31, 2021 | 1,576.00 |
| Dec 31, 2020 | 4,204.00 |
| Dec 31, 2020 | 4,204.00 |
| Sep 30, 2020 | 4,204.00 |
| Sep 30, 2020 | 4,204.00 |
| Dec 31, 2019 | 8,407.00 |
| Dec 31, 2019 | 8,407.00 |